App-tastic hope: smartphone tool aims to shrink fatty livers

NCT ID NCT05180760

Ongoing Disease control Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a smartphone app can help Chinese adults with non-alcoholic fatty liver disease (NAFLD) lose weight over 12 months. Weight loss is currently the only proven way to reverse liver fat and prevent serious complications. The trial will enroll 260 participants, with half using the app and half receiving standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: smartphone app
What this could lead to: If it works, this could offer a simple, scalable tool to help people with fatty liver disease lose weight and improve liver health.
What could go wrong: This is a small pilot study, so results may not apply broadly. The app may not lead to meaningful weight loss, and long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-ALCOHOLIC FATTY LIVER DISEASE

Contacts and locations

Locations

The University of Hong Kong

Hong Kong, 0000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.